The news flow gates just opened. The Head 2 Head can land anytime.
- Forums
- ASX - By Stock
- CU6
- Ann: First patient imaged in Phase III AMPLIFY trial
CU6
clarity pharmaceuticals ltd
Add to My Watchlist
9.57%
!
$2.29

Ann: First patient imaged in Phase III AMPLIFY trial, page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.29 |
Change
0.200(9.57%) |
Mkt cap ! $736.1M |
Open | High | Low | Value | Volume |
$2.09 | $2.31 | $2.07 | $5.472M | 2.463M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
29 | 11144 | $2.28 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.29 | 3723 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
23 | 10962 | 2.280 |
16 | 45033 | 2.270 |
15 | 53582 | 2.260 |
10 | 83206 | 2.250 |
3 | 27876 | 2.240 |
Price($) | Vol. | No. |
---|---|---|
2.290 | 4840 | 8 |
2.300 | 25677 | 19 |
2.310 | 50174 | 15 |
2.320 | 42303 | 14 |
2.330 | 36100 | 8 |
Last trade - 12.51pm 26/06/2025 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |
The Watchlist
3DA
AMAERO LTD
Hank Holland, Chairman & CEO
Hank Holland
Chairman & CEO
Previous Video
Next Video
SPONSORED BY The Market Online